Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology

PURPOSE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have cardiorenal protective effects regardless of whether they are combined with type 2 diabetes mellitus, but their specific pharmacological mechanisms remain undetermined. MATERIALS AND METHODS: We used databases to obtain information on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Anzhu, Li, Zhendong, Zhuo, Sun, Gao, Feng, Zhang, Hongwei, Zhang, Zhibo, Ren, Gaocan, Ma, Xiaochang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169967/
https://www.ncbi.nlm.nih.gov/pubmed/35677689
http://dx.doi.org/10.3389/fcvm.2022.857952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169967/
https://www.ncbi.nlm.nih.gov/pubmed/35677689
http://dx.doi.org/10.3389/fcvm.2022.857952

Ejemplares similares